Interviews - Page 3 of 5
A multi-pathology AI “copilot” that analyzes chest/abdomen CTs. It detects, segments, and packages results for over 20 acute pathologies in parallel targeting emergency department. We asked the founder of xAID, Kirill Lopatin, to walk us through the system’s core workflow.
Theranostics in nuclear medicine is a modern, mainstream approach that unites cancer diagnosis and treatment into a single, integrated system. It not only enables precise identification of tumors and their metastases but also allows targeted radionuclide therapy. Today, these methods are increasingly being included in international treatment protocols and offer patients a real chance to extend their lives and improve quality of life.
We live in a world where data means a lot. But what if some of that data only creates the illusion of control, while actually making it harder to make decisions? This uncomfortable truth was explored in depth by Irina McLean, Health and Social Care Research Coordinator at NHS Research Scotland.